A waterfall of susceptibility results: impact of microbiology testing cascade for MDROs.

Antimicrobial stewardship Carbapenem-resistant enterobacteriaceae (CRE) Gram negative Microbiology Pseudomonas aeruginosa Resistance

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 07 01 2022
revised: 03 05 2022
accepted: 22 05 2022
pubmed: 17 7 2022
medline: 3 8 2022
entrez: 16 7 2022
Statut: ppublish

Résumé

Cascade reporting is an antimicrobial stewardship strategy which selectively reports broad-spectrum antibiotic susceptibility when narrower-spectrum agents are resistant. Three regional laboratories, which provide microbiology services for HCA Healthcare hospitals in Florida, implemented a standardized antibiotic testing cascade for multi-drug resistant organisms. This study evaluated the impact of the testing cascade on time to susceptibility results for carbapenem-resistant Gram-negative organisms. Appropriateness of manual susceptibility test selection was also assessed. Compliance with the testing cascade was 56%. Appropriateness of manual tests in the pre- and post-intervention groups was 87% (257/297) and 96% (310/323), respectively (P < 0.0001). Median time to first manual test result was 23.1 hours (IQR: 19.8-25.2 hours) in the pre-intervention group and 23.9 hours (IQR: 20.2-27.0 hours) in the post-intervention group (P = 0.11). Implementation of a testing cascade did not result in faster manual susceptibility results, however there was a significant increase in testing appropriateness.

Identifiants

pubmed: 35841735
pii: S0732-8893(22)00097-9
doi: 10.1016/j.diagmicrobio.2022.115731
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115731

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflicts of interest relevant to this article.

Auteurs

Kathryn Hernando (K)

HCA North Florida Division, Jacksonville, FL, USA. Electronic address: Kathryn.Hernando@healthtrustpg.com.

Latoy Waite (L)

HCA Florida North Florida Hospital, Gainesville, FL, USA.

Nora Bairagdar (N)

HCA Florida North Florida Hospital, Gainesville, FL, USA.

Kayihura Manigaba (K)

HCA Florida North Florida Hospital, Gainesville, FL, USA.

Keith Teelucksingh (K)

HCA South Atlantic Division, Charleston, SC, USA.

Ryan Dunn (R)

HCA West Florida Division, Largo, FL, USA.

Aida Casiano-Colon (A)

HCA Integrated Regional Laboratories, Fort Lauderdale, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH